Skip to content

Hyaluronic Acid and Amino Acid Combination Versus Exercise for Chronic Lateral Epicondylitis

A New Era in the Treatment of Chronic Lateral Epicondylitis: Comparison of Targeted Biological Support Using a Hyaluronic Acid and Amino Acid Combination Versus Exercise Therapy: A Retrospective, Controlled Clinical Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07410663
Enrollment
60
Registered
2026-02-13
Start date
2025-12-01
Completion date
2026-05-01
Last updated
2026-02-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lateral Epicondylitis

Brief summary

This retrospective, controlled clinical study aims to evaluate the effectiveness of a targeted biological support injection containing a hyaluronic acid and amino acid combination in patients with chronic lateral epicondylitis (tennis elbow). Medical records will be reviewed to compare outcomes between patients treated in routine clinical practice with a 3-dose injection regimen (weeks 0, 2, and 4) plus a home exercise program and those treated with a home exercise program alone. Key outcome measures include pain intensity (VAS), functional status (PRTEE), grip strength, and pressure pain threshold.

Interventions

DRUGHyaluronic Acid + Amino Acid Injection

3-dose injection protocol administered at weeks 0, 2, and 4.

BEHAVIORALHome Exercise Program

Standardized home exercise program for chronic lateral epicondylitis.

Sponsors

Sivas State Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Patients aged between 18 and 70 years. * Patients diagnosed with Lateral Epicondylitis (LE). * Presence of symptoms persisting for 6 weeks or longer. * Patients who were treated with either a 3-dose protocol of Hyaluronic Acid + Amino Acid injection combined with a home exercise program, or a home exercise program alone.

Exclusion criteria

* History of rheumatic disease. * History of malignancy. * Presence of radiculopathy or neuropathy. * Presence of peripheral circulatory disorders. * Congenital or acquired upper extremity deformities. * History of coagulopathy or current use of warfarin therapy. * Presence of prosthesis, metal implant, or internal fixator in the elbow region.

Design outcomes

Primary

MeasureTime frameDescription
Change in Pain Intensity (VAS)Baseline, Week 4, and Month 3Pain intensity will be measured using a 10-cm Visual Analog Scale (VAS).

Secondary

MeasureTime frameDescription
Change in Functional Status (PRTEE Score)Baseline, Week 4, and Month 3Functional disability and pain will be assessed using the Patient-Rated Tennis Elbow Evaluation (PRTEE).
Change in Grip Strength (Hand Dynamometer)Baseline, Week 4, and Month 3Grip strength will be measured using a hand-held dynamometer. Measurements will be recorded in kilograms (kg). Higher values indicate greater strength.
Change in Pressure Pain Threshold (Algometry)Baseline, Week 4, and Month 3Pressure pain threshold over the common extensor tendon will be measured using a handheld algometer.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 14, 2026